Reviewing ReWalk Robotics (RWLK) & Its Competitors
ReWalk Robotics (NASDAQ: RWLK) is one of 26 public companies in the “Surgical appliances & supplies” industry, but how does it compare to its competitors? We will compare ReWalk Robotics to related companies based on the strength of its risk, profitability, dividends, valuation, earnings, institutional ownership and analyst recommendations.
Insider and Institutional Ownership
2.5% of ReWalk Robotics shares are owned by institutional investors. Comparatively, 54.5% of shares of all “Surgical appliances & supplies” companies are owned by institutional investors. 6.9% of ReWalk Robotics shares are owned by insiders. Comparatively, 10.4% of shares of all “Surgical appliances & supplies” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
ReWalk Robotics has a beta of 0.56, meaning that its stock price is 44% less volatile than the S&P 500. Comparatively, ReWalk Robotics’ competitors have a beta of 0.84, meaning that their average stock price is 16% less volatile than the S&P 500.
This is a breakdown of current ratings and recommmendations for ReWalk Robotics and its competitors, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|ReWalk Robotics Competitors||123||705||1254||53||2.58|
ReWalk Robotics presently has a consensus price target of $2.80, suggesting a potential upside of 154.52%. As a group, “Surgical appliances & supplies” companies have a potential upside of 0.27%. Given ReWalk Robotics’ stronger consensus rating and higher probable upside, research analysts clearly believe ReWalk Robotics is more favorable than its competitors.
This table compares ReWalk Robotics and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|ReWalk Robotics Competitors||-295.29%||-52.73%||-18.42%|
Earnings & Valuation
This table compares ReWalk Robotics and its competitors revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|ReWalk Robotics||$7.75 million||-$24.71 million||-1.11|
|ReWalk Robotics Competitors||$1.33 billion||$194.17 million||23.46|
ReWalk Robotics’ competitors have higher revenue and earnings than ReWalk Robotics. ReWalk Robotics is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
ReWalk Robotics competitors beat ReWalk Robotics on 10 of the 13 factors compared.
About ReWalk Robotics
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe. It is also developing ReWalk Restore, a soft suit exoskeleton for individuals who have suffered a stroke. ReWalk Robotics Ltd. markets and sells its products directly to third party payers, institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokne'am Illit, Israel.
Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.